OA01.02 | Monoclonal antibodies with ultra-long CDRH3 derived from vaccinated cows show exceptional neutralisation potency and breadth that is retained after Fc engineering | Oral Abstract Session | Humoral immunity |
OA01.01 | Evaluation of the kinetics of systemic distribution of IV injected monoclonal antibodies modified to alter host mediated Fc interaction in the rhesus macaque model | Oral Abstract Session | Broadly neutralizing antibodies |
HY01.02LB | Long acting injectable cabotegravir is safe and effective in preventing HIV infection in cisgender women: interim results from HPTN 084 | Oral Abstract Session | Clinical trial results |
HY01.01LB | VRC01 antibody prevention of HIV | Oral Abstract Session | Clinical trial results |